发明名称 Two heteroaryl or aryl containing compounds covalently attached via a linker useful as muscarinic receptor antagonists
摘要 A multibinding compound of formula L-X-L (I) wherein: each L is independently a compound of formula (a), (b), (c), (d), (e), (f), (g) or (h) and X is Xa-Z-(Ya-Z)m-Yb-Z-Xa; m is 0 to 20; each Xa is independently -O-, -S-, -NR-, -C(O)-, -C(O)O-, -C(O)NR-, -C(S)-, -C(S)O-, -C(S)NR- or a covalent bond; each Z is independently optionally substituted alkylene, cycloalkylene, alkenylene, alkynylene, cycloalkenylene or arylene, heteroarylene, heterocyclene, or a covalent bond; Ya and Yb are independently -O-, -C(O)-, -OC(O)-, -C(O)O-, -NR-, -S(O)n-, -C(O)NR'-, -NR'C(O)-, -NR'C(O)NR'-, -NR'C(S)NR'-, -C(=NR')-NR'-, -NR'-C(=NR')-, -OC(O)-NR'-, -NR'-C(O)-O-, -N=C(Xa)-NR'-, -NR'-C(Xa)=N-, -P(O)(OR')-O-, -O-P(O)(OR')-, S(O)nCR'R"-, -S(O)n-NR'-, -NR'-S(O)n-, -S-S- or a covalent bond; A is an aryl or a heteroaryl ring; B is a heterocycloamino group, which optionally attaches X to L; C is an aryl or heteroaryl ring, which optionally attaches the ligand to a linker; GÆ is pyrrolidine, piperidine or a group of formula (2) which optionally attaches L to X; G is aryl, heteroaryl heterocyclic or cycloalkyl, which optionally attaches L to X P is aryl or heteroaryl ring which optionally attaches L to X; S is heterocycloamino which optionally attaches L to X; R20 and R21 are independently hydrogen, alkyl or a covalent bond attaching L to X or together with the nitrogen atom to which they are attached form a heterocycloamino ring, which optionally attaches L to X; R25 and R26 are independently hydrogen, alkyl, aralkyl, or a covalent bond attaching L to X or together with the nitrogen atom to which they are attached form a heterocycloamino group, which optionally attaches L to X; D" is alkylene; D is NR31R32, -N+(R33R34R35) or -OR32; F is -NR40-, -O-, -S- or ûCHR41-; F" is a covalent bond, -OR43, -NR42R43 or -N+R43R44R45 and the rest of the variables are as defined in the specification. The compounds are useful for treating a disease mediated by muscarinic receptor such as chronic obstructive pulmonary disease, chronic bronchitis, irritable bowel syndrome or urinary incontinence.
申请公布号 NZ505329(A) 申请公布日期 2003.05.30
申请号 NZ19990505329 申请日期 1999.06.07
申请人 THERAVANCE, INC 发明人 MAMMEN, MATHAI;OARE, DAVID;GRIFFIN, JOHN H;AGGEN, JAMES
分类号 G01N33/53;A01N43/00;A01N55/02;A61K31/135;A61K31/33;A61K31/40;A61K31/404;A61K31/44;A61K31/4427;A61K31/4439;A61K31/445;A61K31/45;A61K31/4523;A61K31/454;A61K31/4545;A61K31/455;A61K31/498;A61K38/00;A61K38/16;A61K39/00;A61K39/395;A61K39/44;A61K51/00;A61P1/04;A61P1/06;A61P11/00;A61P11/06;A61P13/00;A61P43/00;C07B61/00;C07C217/10;C07D207/08;C07D209/00;C07D209/32;C07D209/48;C07D211/00;C07D211/44;C07D211/46;C07D221/24;C07D401/06;C07D401/12;C07D401/14;C07D403/06;C07D451/00;C07D451/06;C07D451/10;C07D487/18;C07K2/00;C07K4/00;C07K5/02;C40B20/00;C40B40/02;C40B40/04;C40B50/06;C40B60/10;G01N33/543;G01N33/566 主分类号 G01N33/53
代理机构 代理人
主权项
地址